ArticleBritish journal of clinical pharmacology2022

COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximab.

Eileen B Doyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.